CD8A and neoplasm: Beyond their direct cytotoxicity, accumulating evidence indicates that CD8+ TExos contribute to remodeling the tumor microenvironment, enhancing antitumor immunity in coordination with other immune components.[256] Their ability to synergize direct cytotoxicity with secondary immune amplification renders them attractive agents for combination with checkpoint inhibitors or neoantigen‐targeted strategies.